EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

CaCl 2 -Citrate Regional Anticoagulation with Continuous Veno-Venous Haemodialysis Leads to Unwanted Chloride Loading Compared to Continuous Veno-Venous Hemofiltration with Systemic Anticoagulation

Matthieu Chivot, Ian Baldwin, Guillaume Deniel, Guillaume David, Glenn M Eastwood, Jean-Christophe Richard, Rinaldo Bellomo, Laurent Bitker

Blood Purification · 2024

DOI: 10.1159/000541059 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Blood Purification, 2024. Verfasst von Matthieu Chivot und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Intensive - Réanimation, hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Anticoagulants, Citric Acid, Continuous Renal Replacement Therapy, Chlorides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chloride transfers during continuous renal replacement therapy (CRRT) have not been adequately described and may differ based on CRRT technique. We aimed to measure chloride mass transfer (JS,Cl) during CRRT and identify associated determinants.

Methods

We performed a two-centre, prospective, observational study in France and Australia in ICU patients with CRRT initiated for <24 h. Patients received continuous veno-venous hemofiltration (CVVH) or continuous veno-venous haemodialysis (CVVHD, with citrate-CaCl2 regional anticoagulation). Over a 24 h period, plasma and effluent chloride concentrations were measured every 4 h to compute chloride mass transfer (JS,Cl, in mmol.min-1) using a modality-specific model, with negative value indicating chloride transfer towards the patient. Secondary outcomes were the identification of CRRT settings associated with JS,Cl (using multivariate mixed effects regression). Results are presented with median (interquartile range).

Results

Between February 2021 and August 2022, we enrolled 37 patients (64 [56–71] years, 67% male), for a total of 20 CVVHD and 20 CVVH sessions. Over 24 h, plasma chloride concentrations were significantly higher, and JS,Cl significantly lower during CVVHD, compared to CVVH (−0.10 [−0.33 to 0.15] vs. 0.01 [−0.10 to 0.13] mmol.min-1, p < 0.05). With both modalities, net ultrafiltration (QUFNET) and plasma chloride concentrations were the principal determinants of JS,Cl, with higher QUFNET being associated with an increase in JS,Cl during CVVHD. Also, CVVHD sessions demonstrated a concentration gradient between the plasma and the effluent chamber of −6 [−9 to −4] mmol.L-1. Finally, CaCl2 reinjection during CVVHD accounted for 35% [32–60%] of total JS,Cl in sessions with a negative JS,Cl.

Conclusion

Compared to CVVH, CVVHD with regional citrate anticoagulation was associated with greater chloride mass transfer to the patient and higher plasma chloride concentrations. This was due to high dialysate chloride concentrations and CaCl2 reinjection. This effect could only be controlled by high net ultrafiltration flow rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsCitric AcidContinuous Renal Replacement TherapyChloridesRenal DialysisHumansMaleMiddle AgedFemaleAgedProspective StudiesHemofiltrationCalcium Chloride

Stichwörter der Autor:innen

Calcium-citrate regional anticoagulationChlorideContinuous renal replacement therapyNet ultrafiltration

Substanzen

AnticoagulantsCitric AcidChloridesCalcium Chloride

Autor:innen und Institutionen

  • Service de Médecine Intensive - Réanimation, hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.
  • University Lyon, Université Claude Bernard Lyon 1, INSA-Lyon, CNRS, INSERM, CREATIS UMR, U1294, Villeurbanne, France.
  • Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
  • Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.

Zitieren

APA

Chivot, M., Baldwin, I., Deniel, G., David, G., Eastwood, G. M., Richard, J. C., Bellomo, R., & Bitker, L. (2024). CaCl 2 -Citrate Regional Anticoagulation with Continuous Veno-Venous Haemodialysis Leads to Unwanted Chloride Loading Compared to Continuous Veno-Venous Hemofiltration with Systemic Anticoagulation. Blood Purification. https://doi.org/10.1159/000541059

Vancouver

Chivot M, Baldwin I, Deniel G, David G, Eastwood GM, Richard JC, et al. CaCl 2 -Citrate Regional Anticoagulation with Continuous Veno-Venous Haemodialysis Leads to Unwanted Chloride Loading Compared to Continuous Veno-Venous Hemofiltration with Systemic Anticoagulation. Blood Purification. 2024. doi:10.1159/000541059

BibTeX
@article{Chivot2024,
  author = {Chivot, Matthieu and Baldwin, Ian and Deniel, Guillaume and David, Guillaume and Eastwood, Glenn M and Richard, Jean-Christophe and Bellomo, Rinaldo and Bitker, Laurent},
  title = {CaCl 2 -Citrate Regional Anticoagulation with Continuous Veno-Venous Haemodialysis Leads to Unwanted Chloride Loading Compared to Continuous Veno-Venous Hemofiltration with Systemic Anticoagulation},
  journal = {Blood Purification},
  year = {2024},
  doi = {10.1159/000541059}
}
Kostenlos starten →